Hypothermia With Intrajugular Cooling in Acute Ischemic Stroke Thrombectomy
PICNIC
Safety and Tolerability of Intrajugular Cooling in Patients With Acute Ischemic Stroke After Mechanical Thrombectomy
1 other identifier
interventional
15
0 countries
N/A
Brief Summary
Hypothermia with intrajugular cooling is a neuroprotective strategy that has been proven to minimize brain damage and maximize functional preservation in animal models of stroke. The purpose of this proof-of-concept study is to determine the safety and tolerability of intrajugular cooling in patients with acute ischemic stroke who are treated with mechanical thrombectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2022
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 3, 2022
CompletedFirst Posted
Study publicly available on registry
August 4, 2022
CompletedStudy Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2024
CompletedAugust 4, 2022
August 1, 2022
1 year
August 3, 2022
August 3, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants with major response
Major response is any of the following: 1. Cerebral venous system damage; 2. Cerebral venous thrombosis; 3. Huge hematoma at the puncture site requiring surgical intervention; 4. Malignant arrhythmia within 24 hours; 5. Cardiac arrest within 24 hours; 6. Myocardial infarction within 24 hours; 7. Congestive heart failure within 24 hours. In the 3 + 3 design, 3 subjects are recruited for a given intrajugular cooling dose level. The trial is stopped if ≥ 2 of 3 subjects at a given dose level show major response. If only 1 of 3 subjects shows major response, 3 more subjects are recruited at a given dose level and a major response in any of them will stop the trial. Otherwise, same procedure is followed for the next dose level. Maximum tolerable dose will be the dose at the level before stopping of the trial. The schedule of advancing duration is 10 min, 15 min, 20 min, 25 min, and 30 min.
Within 24 hours after hypothermia with intrajugular cooling
Study Arms (1)
Intrajugular cooling group
EXPERIMENTALThe safety and tolerability of hypothermia with intrajugular cooling will be investigated using 3+3 dose-escalation trial design.
Interventions
Hypothermia with intrajugular cooling will be applied after successful recanalization of the culprit internal carotid artery/middle cerebral artery. The perfusion rate will be set at 30 ml/min. Low temperature saline will be infused into the internal jugular vein for 10 min, 15 min, 20 min, 25 min, and 30 min successively.
Eligibility Criteria
You may qualify if:
- Age 18-80 years;
- Acute ischemic stroke caused by unilateral internal carotid artery terminal segment/middle cerebral artery M1 segment occlusion;
- In line with the indications for mechanical thrombectomy without contraindications;
- Successful recanalization (mTICI 2b/3) after mechanical thrombectomy that confirmed by digital subtraction angiography;
- Written informed consent provided by the patients or their legal relatives.
You may not qualify if:
- Suffering from cerebral venous system diseases such as cerebral venous thrombosis/stenosis/dysplasia;
- Suffering from heart diseases such as ventricular arrhythmia/myocardial infarction/congestive heart failure;
- Imaging examination after mechanical thrombectomy shows intracranial hemorrhage/contrast extravasation;
- Difficulty in reaching the designated position of the device used for intrajugular cooling;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 3, 2022
First Posted
August 4, 2022
Study Start
November 1, 2022
Primary Completion
November 1, 2023
Study Completion
February 1, 2024
Last Updated
August 4, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will share
Related data will be shared if full study protocol and statistical analysis plan are provided with reasonable design.